MedTrace Logo

Hemodynamically Important Patent Ductus Arteriosus in Newborns Under 32 Weeks

NCT05686343 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2023-01-17

No results posted yet for this study

Summary

To define the characteristics of hemodynamically significant PDA by echocardiography, to investigate the systemic effects of the ductus with cerebral and renal Doppler flow studies, and to determine the oxygen consumption in the cerebral tissue with NIRS in newborns below 32 weeks of age with PDA.

Conditions

  • Patent Ductus Arteriosus After Premature Birth

Interventions

DIAGNOSTIC_TEST

Echocardiography, Doppler ultrasonography, Near-infrared spectroscopy

Ecocardiography at 1st, 3rd and 7th day of life Doppler US (cranial and renal) at 1st, 3rd and 7th day of life Near-infrared spectroscopy monitoring after birth during first 3-days of life

Sponsors & Collaborators

  • Ankara University

    lead OTHER

Principal Investigators

  • Özlem Bayram · Ankara University

Eligibility

Min Age
1 Minute
Max Age
7 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2023-07-01
Completion
2023-07-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05686343 on ClinicalTrials.gov